115 related articles for article (PubMed ID: 38317368)
21. Identification of a novel pathogenic MLH1 mutation and recommended genetic screening strategy: An investigation of three Chinese Lynch syndrome pedigrees.
Li F; Xia Y; Wang G; Tang C; Zhan T; Shen J; Zhang J
Mol Genet Genomic Med; 2020 Aug; 8(8):e1295. PubMed ID: 32490589
[TBL] [Abstract][Full Text] [Related]
22. Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies.
Ryan NAJ; Morris J; Green K; Lalloo F; Woodward ER; Hill J; Crosbie EJ; Evans DG
JAMA Oncol; 2017 Dec; 3(12):1702-1706. PubMed ID: 28772289
[TBL] [Abstract][Full Text] [Related]
23. Identification of novel Lynch syndrome mutations in Chinese patients with endometriod endometrial cancer.
Ren C; Liu Y; Wang Y; Tang Y; Wei Y; Liu C; Zhang H
Cancer Biol Med; 2020 May; 17(2):458-467. PubMed ID: 32587781
[No Abstract] [Full Text] [Related]
24. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
[TBL] [Abstract][Full Text] [Related]
25. Next Generation Sequencing Reveals Novel Mutations in Mismatch Repair Genes and Other Cancer Predisposition Genes in Asian Patients with Suspected Lynch Syndrome.
Ow SGW; Tan KT; Yang H; Yap HL; Sapari NSB; Ong PY; Soong R; Lee SC
Clin Colorectal Cancer; 2019 Dec; 18(4):e324-e334. PubMed ID: 31350202
[TBL] [Abstract][Full Text] [Related]
26. Universal screening for Lynch syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular features.
Jiang W; Cai MY; Li SY; Bei JX; Wang F; Hampel H; Ling YH; Frayling IM; Sinicrope FA; Rodriguez-Bigas MA; Dignam JJ; Kerr DJ; Rosell R; Mao M; Li JB; Guo YM; Wu XY; Kong LH; Tang JH; Wu XD; Li CF; Chen JR; Ou QJ; Ye MZ; Guo FM; Han P; Wang QW; Wan DS; Li L; Xu RH; Pan ZZ; Ding PR;
Int J Cancer; 2019 May; 144(9):2161-2168. PubMed ID: 30521064
[TBL] [Abstract][Full Text] [Related]
27. Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins.
Jaballah-Gabteni A; Tounsi H; Kabbage M; Hamdi Y; Elouej S; Ben Ayed I; Medhioub M; Mahmoudi M; Dallali H; Yaiche H; Ben Jemii N; Maaloul A; Mezghani N; Abdelhak S; Hamzaoui L; Azzouz M; Boubaker S
J Transl Med; 2019 Jun; 17(1):212. PubMed ID: 31248416
[TBL] [Abstract][Full Text] [Related]
28. Contribution of MLH1 constitutional methylation for Lynch syndrome diagnosis in patients with tumor MLH1 downregulation.
Pinto D; Pinto C; Guerra J; Pinheiro M; Santos R; Vedeld HM; Yohannes Z; Peixoto A; Santos C; Pinto P; Lopes P; Lothe R; Lind GE; Henrique R; Teixeira MR
Cancer Med; 2018 Feb; 7(2):433-444. PubMed ID: 29341452
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer.
Vietri MT; D'Elia G; Caliendo G; Casamassimi A; Federico A; Passariello L; Cioffi M; Molinari AM
Med Oncol; 2021 Jan; 38(2):13. PubMed ID: 33484353
[TBL] [Abstract][Full Text] [Related]
30. Identification of Lynch syndrome risk variants in the Romanian population.
Iordache PD; Mates D; Gunnarsson B; Eggertsson HP; Sulem P; Benonisdottir S; Csiki IE; Rascu S; Radavoi D; Ursu R; Staicu C; Calota V; Voinoiu A; Jinga M; Rosoga G; Danau R; Sima SC; Badescu D; Suciu N; Radoi V; Mates IN; Dobra M; Nicolae C; Kristjansdottir S; Jonasson JG; Manolescu A; Arnadottir G; Jensson B; Jonasdottir A; Sigurdsson A; le Roux L; Johannsdottir H; Rafnar T; Halldorsson BV; Jinga V; Stefansson K
J Cell Mol Med; 2018 Dec; 22(12):6068-6076. PubMed ID: 30324682
[TBL] [Abstract][Full Text] [Related]
31. A Novel Germline
Klančar G; Blatnik A; Šetrajčič Dragoš V; Vogrič V; Stegel V; Blatnik O; Drev P; Gazič B; Krajc M; Novaković S
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32197529
[TBL] [Abstract][Full Text] [Related]
32. Evidence for classification of c.1852_1853AA>GC in MLH1 as a neutral variant for Lynch syndrome.
Castillejo A; Guarinos C; Martinez-Canto A; Barbera VM; Egoavil C; Castillejo MI; Perez-Carbonell L; Sanchez-Heras AB; Segura A; Ochoa E; Lazaro R; Ruiz-Ponte C; Bujanda L; Andreu M; Castells A; Carracedo A; Llor X; Clofent J; Alenda C; Paya A; Jover R; Soto JL
BMC Med Genet; 2011 Jan; 12():12. PubMed ID: 21247423
[TBL] [Abstract][Full Text] [Related]
33. The First Molecular Screening of MLH1 and MSH2 Genes in Moroccan Colorectal Cancer Patients Shows a Relatively High Mutational Prevalence.
Moufid FZ; Bouguenouch L; El Bouchikhi I; Chbani L; Iraqui Houssaini M; Sekal M; Belhassan K; Bennani B; Ouldim K
Genet Test Mol Biomarkers; 2018 Aug; 22(8):492-497. PubMed ID: 30044143
[TBL] [Abstract][Full Text] [Related]
34. Somatic mosaicism by a de novo MLH1 mutation as a cause of Lynch syndrome.
Geurts-Giele WR; Rosenberg EH; Rens AV; Leerdam MEV; Dinjens WN; Bleeker FE
Mol Genet Genomic Med; 2019 Jul; 7(7):e00699. PubMed ID: 31104363
[TBL] [Abstract][Full Text] [Related]
35.
Carnevali IW; Cini G; Libera L; Sahnane N; Facchi S; Viel A; Sessa F; Tibiletti MG
Genes (Basel); 2023 Nov; 14(11):. PubMed ID: 38003003
[TBL] [Abstract][Full Text] [Related]
36. A novel frameshift mutation in the
Pandey AS; Shrestha S
Indian J Cancer; 2018; 55(4):410-412. PubMed ID: 30829280
[TBL] [Abstract][Full Text] [Related]
37. Association of a novel frameshift variant and a known deleterious variant in MMR genes with Lynch syndrome in Chinese families.
Li J; Ni H; Wang X; Cheng W; Li L; Cheng Y; Liu C; Li Y; Deng A
World J Surg Oncol; 2024 Jan; 22(1):36. PubMed ID: 38280988
[TBL] [Abstract][Full Text] [Related]
38. A Novel
Zhang Y; Chen H; Peng Z; Banerjee S; Li W; Zhao Z; Sun J; Lv J; Huang H; Bai R; Lin K; Li Z
Biomed Res Int; 2018; 2018():1460835. PubMed ID: 30539002
[TBL] [Abstract][Full Text] [Related]
39. Co-occurrence of germline pathogenic variants for different hereditary cancer syndromes in patients with Lynch syndrome.
Ferrer-Avargues R; Castillejo MI; Dámaso E; Díez-Obrero V; Garrigos N; Molina T; Codoñer-Alejos A; Segura Á; Sánchez-Heras AB; Castillejo A; Soto JL
Cancer Commun (Lond); 2021 Mar; 41(3):218-228. PubMed ID: 33630411
[TBL] [Abstract][Full Text] [Related]
40. MLH1 promoter hypermethylation: are you absolutely sure about the absence of MLH1 germline mutation? About a new case.
Kientz C; Prieur F; Clemenson A; Joly MO; Stachowicz ML; Auclair J; Attignon V; Schiappa R; Wang Q
Fam Cancer; 2020 Jan; 19(1):11-14. PubMed ID: 31745674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]